Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Study records: PCO-02 safety and pharmacokinetics trial, Pentadecapeptide BPC 157 for Acute Grade II Hamstring Strain (NCT07437547), Intra-articular injection of BPC 157 for multiple types of knee pain, Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study, Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review, A new gastric juice peptide, BPC, and characterization of its 15 amino acid fragment BPC 157, BPC-157 protection against gastric and duodenal lesions in rat ulcer models Evidence boundary: These records do not test the vial, capsule, nasal-spray, and topical formats observed in the research-use market, and the preclinical findings do not establish human efficacy for any indication
Plasma levels drop from approximately 200ng/ml at age 20 to 80ng/ml by age 60
Legal notice: BPC-157 is a research peptide and not an approved medicine
it does not support a clinical recommendation, including for athletes with tendon injuries
and prescription nootropics like L-dopa and modafinil
Researchers at Monash University recognized that many individuals seeking fat loss could not tolerate or did not need growth hormones broader effects including muscle growth, glucose elevation, and IGF-1 stimulation
US$ 22.59
US$ 28.42
US$ 26.47
US$ 28.56
US$ 29.74
US$ 20.24
